Pharmacists in Peru, IL Accepting Medicare

17 Pharmacists found. Showing 1 - 17

Laura Beth Urbanski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1651 Midtown Rd, Peru, IL 61354 Phone: 815-223-4276    Fax: 815-223-4957

Alyssa Butkiewicz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1033 Shooting Park Rd, Peru, IL 61354 Phone: 815-223-7853

Kristin Dwyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1033 Shooting Park Rd, Peru, IL 61354 Phone: 815-223-7853

Tina Marie Dominy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5307 State Route 251, Peru, IL 61354 Phone: 815-224-1508    Fax: 815-224-8003

Julie Pleskovitch, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1651 Midtown Rd, Peru, IL 61354 Phone: 815-223-4276    Fax: 815-223-4957

Dawn Sorensen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1651 Midtown Rd, Peru, IL 61354 Phone: 815-223-4276

Mrs. Karissa Lee Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4370 Venture Dr, T0929, Peru, IL 61354 Phone: 815-224-2408    Fax: 815-224-2408

Timothy Ricci, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1004 Shooting Park Rd, Peru, IL 61354 Phone: 815-224-1411

Mrs. Donna Kay Morscheiser, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 West St, Peru, IL 61354 Phone: 815-224-4555    Fax: 815-223-8349

Brian E Duttlinger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 West St, Peru, IL 61354 Phone: 815-224-4555

Ms. Diane Marie Harrod, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4370 Venture Dr, T0929, Peru, IL 61354 Phone: 815-224-2408    Fax: 815-224-2408

David Bourbonnais Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1004 Shooting Park Rd, Peru, IL 61354 Phone: 815-224-1411

Tracy Louise Kotecki Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1004 Shooting Park Rd, Peru, IL 61354 Phone: 815-224-1411

Mr. David Bernerd Brandner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1033 Shooting Park Rd, Peru, IL 61354 Phone: 815-223-7853    Fax: 815-223-0978

Patcharaporn Keane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1004 Shooting Park Rd, Peru, IL 61354 Phone: 815-224-1411

Jacob Joachim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1033 Shooting Park Rd, Peru, IL 61354 Phone: 815-223-7853

Michele Walker Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1033 Shooting Park Rd, Peru, IL 61354 Phone: 815-223-7853    Fax: 815-223-0978

News Archive

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.

Study reveals the regulatory mechanism of protein kinase A

Research conducted at the University of California, San Diego (UCSD) School of Medicine has shed new light on the structure and function of one of the key proteins in all mammalian cells, protein kinase A (PKA), an enzyme which plays an essential role in memory formation, communication between nerve cells, and cardiac function.

FDA approves IND application by Octapharma USA for severe COVID-19 patients

The U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression.

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

Read more Medical News

› Verified 7 days ago